Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,547,000 | 9,007,000 | 9,303,000 | 8,446,000 | 6,088,000 |
| Marketable Securities | 196,000 | 467,000 | 486,000 | 1,108,000 | 1,117,000 |
| Receivables | 5,793,000 | 5,841,000 | 5,088,000 | 4,891,000 | 4,859,000 |
| Inventories | 1,580,000 | 1,738,000 | 1,605,000 | 1,785,000 | 1,582,000 |
| TOTAL | $13,845,000 | $20,444,000 | $21,223,000 | $18,930,000 | $16,962,000 |
| Non-Current Assets | |||||
| PPE Net | 2,787,000 | 2,828,000 | 2,803,000 | 2,697,000 | 2,657,000 |
| Investments And Advances | 1,505,000 | 2,057,000 | 2,090,000 | 1,971,000 | 2,052,000 |
| Intangibles | 42,595,000 | 43,110,000 | 43,344,000 | 43,915,000 | 44,018,000 |
| Other Non-Current Assets | 909,000 | 903,000 | 1,326,000 | 1,327,000 | 1,305,000 |
| TOTAL | $47,796,000 | $48,898,000 | $49,563,000 | $49,910,000 | $50,032,000 |
| Total Assets | $61,641,000 | $69,342,000 | $70,786,000 | $68,840,000 | $66,994,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 6,530,000 | 6,381,000 | 6,415,000 | 3,821,000 | 3,420,000 |
| Accounts payable and accrued liabilities | 10,694,000 | 10,677,000 | 10,226,000 | 9,212,000 | 8,839,000 |
| TOTAL | $17,224,000 | $17,058,000 | $16,641,000 | $13,033,000 | $12,259,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 30,579,000 | 30,906,000 | 30,953,000 | 33,974,000 | 33,817,000 |
| Other Non-Current Liabilities | 15,543,000 | 15,521,000 | 15,605,000 | 8,999,000 | 8,518,000 |
| TOTAL | $47,792,000 | $48,731,000 | $49,048,000 | $49,120,000 | $48,726,000 |
| Total Liabilities | $65,016,000 | $65,789,000 | $65,689,000 | $62,153,000 | $60,985,000 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,514,273 | 1,586,879 | 1,587,973 | 1,596,430 | 1,594,095 |
| Common Shares | 18,000 | 18,000 | 18,000 | 18,000 | 18,000 |
| Retained earnings | 5,495,000 | 4,977,000 | 5,459,000 | 6,547,000 | 5,951,000 |
| Other shareholders' equity | -2,639,000 | -2,630,000 | -2,727,000 | -2,613,000 | -2,548,000 |
| TOTAL | $-3,375,000 | $3,553,000 | $5,097,000 | $6,687,000 | $6,009,000 |
| Total Liabilities And Equity | $61,641,000 | $69,342,000 | $70,786,000 | $68,840,000 | $66,994,000 |